Advanced Malignancies Active Not Recruiting Phase 1 Trials for Cemiplimab (DB14707)

IndicationStatusPhase
DBCOND0030888 (Advanced Malignancies)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02383212Study of REGN2810 (Anti-PD-1) in Patients With Advanced MalignanciesTreatment